Plan to scale back Medicare’s protected drug classes would hurt epilepsy patients
Doctors need the discretion to choose the anticonvulsant drugs most effective at controlling seizures of epileptic patients. Changes proposed by the Centers for Medicare and Medicaid Services could exclude certain drugs from coverage.
Comments
Want to comment on our stories? If you’re a subscriber, scroll down to the comments. If you’re not a subscriber, only paid subscribers can add their thoughts, so subscribe now. Our commenting policy can be viewed here.